DocDollars

Aadi Bioscience, Inc.

NJ · United States · Reporting entity ID 100001176922

Total reported 2019–2025
$54.7M
#161 of 2,960 reporting companies — 0.1% of all reported industry payments
$1.16M in general payments across 1,460 records, plus $52.9M in research funding across 2,673 records.

How it breaks down

General payments $1,155,768
Research funding $52,944,870
Ownership & investment $621,770

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Aadi Bioscience, Inc. reported $54.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #161 of 2,960 reporting companies. 97% of that was research funding and 3% general payments such as consulting, speaking, food and travel. 1,460 general payment records and 2,673 research records were filed.

Common questions about Aadi Bioscience, Inc.

How much has Aadi Bioscience, Inc. paid US doctors?

Aadi Bioscience, Inc. reported $54,722,408 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,155,768 in general payments, $52,944,870 in research funding and $621,770 in ownership and investment interests.

How does Aadi Bioscience, Inc. rank among drug and device companies?

It ranks #161 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Aadi Bioscience, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.